Shanghai's SARI Pays $359M for Italian Cancer Biopharma NMS Post author:Sam Post published:December 28, 2017 Post category:BioPharma The parts expect the closing in the first quarter 2018. Source: BioSpace You Might Also Like This Pharma Giant Doesn't Want Its Drug Used in Death Penalty Executions August 22, 2017 ColonaryConcepts Sells Its Novel Colonoscopy Preparation Assets To A GI-Focused Specialty Pharma Company May 31, 2017 Mesa Labs Declares Quarterly Dividend October 2, 2017
ColonaryConcepts Sells Its Novel Colonoscopy Preparation Assets To A GI-Focused Specialty Pharma Company May 31, 2017
